These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metabolites of demoxepam, a chlordiazepoxide metabolite, in man. Schwartz MA; Postma E J Pharm Sci; 1972 Jan; 61(1):123-5. PubMed ID: 5058629 [No Abstract] [Full Text] [Related]
5. Pharmacokinetic model for chlordiazepoxide--HCl in the dog. Kaplan SA; Lewis M; Schwartz MA; Postma E; Cotler S; Abruzzo CW; Lee TL; Weinfeld RE J Pharm Sci; 1970 Nov; 59(11):1569-74. PubMed ID: 5495479 [No Abstract] [Full Text] [Related]
6. Metabolism, distribution and excretion of the thiophthalane lu 5-003, a bicyclic thymoleptic. Overo KF; Jorgensen A; Hansen V Acta Pharmacol Toxicol (Copenh); 1970; 28(2):81-96. PubMed ID: 4194344 [No Abstract] [Full Text] [Related]
7. Biotransformation of prazepam in man. DiCarlo FJ; Viau JP; Epps JE; Haynes LJ Ann N Y Acad Sci; 1971 Jul; 179():487-92. PubMed ID: 5285388 [No Abstract] [Full Text] [Related]
8. The metabolic alteration of drugs. Schreiber EC Annu Rev Pharmacol; 1970; 10():77-98. PubMed ID: 4392814 [No Abstract] [Full Text] [Related]
9. Distribution and metabolism of 14C-labelled-chlordiazepoxide in mice. Placidi GF; Cassano GB Int J Neuropharmacol; 1968 Jul; 7(4):383-9. PubMed ID: 5720525 [No Abstract] [Full Text] [Related]
10. Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatography. Straughan JL; Cathcart-Rake WF; Shoeman DW; Azarnoff DL J Chromatogr; 1978 Nov; 146(3):473-80. PubMed ID: 363736 [TBL] [Abstract][Full Text] [Related]
11. SOME PHARMACOLOGIC EFFECTS OF INTRAVENOUS OXAZEPAM. STEEN SN; MARTINEZ LR Anesth Analg; 1965; 44():358-62. PubMed ID: 14297328 [No Abstract] [Full Text] [Related]
12. Protein binding and lipophilic nature of ataractics of the meprobamate- and diazepine-group. van der Kleijn E Arch Int Pharmacodyn Ther; 1969 May; 179(1):225-50. PubMed ID: 5387515 [No Abstract] [Full Text] [Related]
13. The absorption, excretion and metabolic fate of mephenoxalone in the dog. Morrison JA Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):385-99. PubMed ID: 5899473 [No Abstract] [Full Text] [Related]
14. Chlordiazepoxide metabolites in the rat. Characterization by high resolution mass spectrometry. Schwartz MA; Vane FM; Postma E Biochem Pharmacol; 1968 Jun; 17(6):965-74. PubMed ID: 5661358 [No Abstract] [Full Text] [Related]
15. The metabolism and excretion of the neuroleptic drug pimozide (R 6238) by the wistar rat. Soudijn W; Van Wijngaarden I Life Sci; 1969 Mar; 8(5):291-5. PubMed ID: 5781318 [No Abstract] [Full Text] [Related]
16. [Spectrophotometric determination of 5-phenyl-1,4-benzodiazepine-derivatives and studies on metabolism of nitrazepam. 5. Chemistry and analytics of benzodiazepine-derivatives]. Beyer KH; Sadée W Arzneimittelforschung; 1969 Dec; 19(12):1929-31. PubMed ID: 5395884 [No Abstract] [Full Text] [Related]
17. Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat, and mouse. Schwartz MA; Postma E; Kolis SJ; Leon AS J Pharm Sci; 1973 Nov; 62(11):1776-9. PubMed ID: 4758074 [No Abstract] [Full Text] [Related]
18. Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat. Soudijn W; Van Wijngaarden I; Allewijn F Eur J Pharmacol; 1967 Jan; 1(1):47-57. PubMed ID: 6058899 [No Abstract] [Full Text] [Related]
19. Relationship between the duration of anticonvulsant activity of chlordiazepoxide and systemic levels of the parent compound and its major metabolites in mice. Coutinho CB; Cheripko JA; Carbone JJ Biochem Pharmacol; 1969 Feb; 18(2):303-16. PubMed ID: 5778149 [No Abstract] [Full Text] [Related]
20. [Radiochromatographic studies of excretion and metabolism of methophenazine (Frenolon) in animal experiments]. Jászsági-Nagy E; Elekes I Pharmazie; 1969 Jun; 24(6):337-8. PubMed ID: 5807396 [No Abstract] [Full Text] [Related] [Next] [New Search]